top of page
Image-empty-state_edited.jpg

CORVIDANE

CORVIDANE Future Equity SAFE 1
Developing a novel, safe drug to prevent heart attacks, strokes and liver transplants for NASH

?/100

Crowd Score

Click to request a score

There is a newer open investment round for this company - click here to view
Our take:
​

Thanks, catch you soon!

Sign up to receive weekly deal alerts and top news

Round Performance

Amount Raised

[]

Average-Investment-Icon-p-1600.png
Average Investment

[]

Average-Daily-Investment-Icon-p-1600.png
Average Per Day

[]

Investors-Icon-p-1600.png
# of Investors

[]

Investors vs. Capital Raised

Investment Type

SAFE

Valuation Cap

$20,000,000

Minimum Investment

$100

Conversion Discount

10%

​

​

Investment Details

Early Bird Perks

Perk description
Perk level (dollars)
Perk level (days)
Loading...

No early bird perks for this round!

Screen Shot 2020-07-15 at 12.01.28 PM.pn

View early bird perks, company financials, valuation methods, and more

Similar Investments

Image-empty-state_edited.jpg
ACHIEVE CLINICS, INC.
Convertible Note
Image-empty-state_edited.jpg
QMed Innovations
Common Stock
Image-empty-state_edited.jpg
WHITEFLAG
Common Stock
bottom of page